Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Car Insurance For Used Cars- Documents, Valuation, and Coverage Tips Business
  • Jadu Tona Reh, a beautiful Hindi love song with superb Gujarati Garba, created by the collaboration of two Gujarati friends, is out now Entertainment
  • North East India’s First & Biggest ever Organic Fair – Expo ONE 2023 Business
  • New Research Highlights ‘Biofilm Shield’ as the Hidden Culprit Behind Recurrent UTIs Health
  • Platinum Stellar by Platinum Corp. with Sussanne Khan: Bespoke Presidential Suites in Santacruz West Business
  • India’s first Global Women’s Health Innovation Conference to highlight potential of femtech & digital innovations Business
  • Meet 10 Influential Visionary Thinkers Building a Better Tomorrow in 2023 Business
  • Indus University Concludes its 7th convocation Ceremony Press Release

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Advanced Treatment for Fistula and Pilonidal Sinus Now Accessible for Palakkad Patients Health
  • Dental Krafts Lead Advanced Dental Implants and Invisalign Treatments in Gurgaon Health
  • Advanced Laser Treatment for Fistula & Pilonidal Sinus in Thrissur – Dr. Raviram S Health
  • Vaccine Delays May Cause Serious Illness in Babies: Advice from 8 Best Pediatricians Health
  • Srimati Sirisha Raghavendra Garu Joins FitFourFreedom Success Celebration at Sravani Hospitals Health
  • Niner Pharmaceuticals Unveils MedTech 9ER Application for Global Healthcare Transformation Health

Recent Posts

  • Complete Guide to Wheat Farming: From Sowing to Harvest in Simple Steps
  • SKYY RIDER ELECTRIC Secures Orders for 500+ Vehicles in Q1 FY 2026-27, Strengthening Its Position in India’s Electric Mobility Sector
  • SDPL Introduces Suvarnabhumi, Expanding Premium Plotted Developments in Nagpur
  • Shikkhar Suri Launches Nationwide Initiative to Prepare 10,000 Indian Professionals for Global Remote Careers
  • How to Make Sense of the AI Funding Boom: A Beginner’s Guide to 2026’s Biggest Deals

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • HSM’s ‘Psychology and Mental Health’ Internship Programme Attracted A Whopping 2200 Students From Across India Press Release
  • Hafele Launches New Loox LED Strip Lights for Smarter Home Lighting Solutions Business
  • Prabhat Arts International Presents ‘18 Days’- The Greatest Dance Musical of India Entertainment
  • India is Poised for Next Evolution Arc in Financial Services with Neobanks: Report Business
  • Greenpanel Industries Ltd. Becomes One of the Most Trusted Brands of India 2026–27 Lifestyle
  • Innvolution Healthcare Celebrates Virtual Inauguration of Jaipur Stent Manufacturing Facility Business
  • Mehul Purohit: A Young Entrepreneur Making Waves in Digital Branding Business
  • Why Gen Z Is Choosing EMIs Over Savings: The Psychology Behind Personal Loans Finance

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme